Dalfampridine
NDC 67877-444, Dalfampridine, tablet, film coated, extended release, from Ascend Laboratories, LLC.
- Product NDC
- 67877-444
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206765
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-444 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DALFAMPRIDINE10 mg/1
Pharmacologic classes
Potassium Channel Antagonists [MoA]; Potassium Channel Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-444-05 | 67877044405 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-05) |
| 67877-444-60 | 67877044460 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-60) |
| 67877-444-90 | 67877044490 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-90) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e10b2d92-2824-4395-8883-6fd52c784aa4NADAC price for package 67877044460
GET /v1/drugs/nadac/67877044460
Use it
Look up 67877-444 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-444 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-444. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.